General Information of Drug Formulation (ID: F22130)

Formulation Name
Vandetanib 100 mg tablet
Company
AstraZeneca
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Vandetanib DMRICNP Solid tumour/cancer 2A00-2F9Z Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Brushite E00392 104805 Diluent
Crospovidone E00626 Not Available Disintegrant
Magnesium stearate E00208 11177 lubricant
Polyethylene glycol 300 E00651 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Povidone E00667 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Water E00035 962 Solvent